Source: Themarketsdaily

Sierra Oncology: Q1 2020 Earnings Estimate for Sierra Oncology Inc (NASDAQ:SRRA) Issued By Oppenheimer

Sierra Oncology Inc (NASDAQ:SRRA) – Oppenheimer lowered their Q1 2020 earnings per share (EPS) estimates for Sierra Oncology in a research report issued on Tuesday, March 3rd. Oppenheimer analyst J.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Stephen Dilly's photo - President & CEO of Sierra

President & CEO

Stephen Dilly

CEO Approval Rating

90/100

Sierra is a clinical-stage drug development company that researches, develops and commercializes therapeutics for the treatment of cancer. Read more